Madhav Hitesh Kumar
About Madhav Hitesh Kumar
Data last updated:
Madhav Hitesh Kumar is a Director at Surgeway Biosciences Private Limited (since 2023) and Director at Dorphyll Healthcare Private Limited (since 2021). The companies operate in Pharma and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹5.26 Cr; the largest is Surgeway Biosciences Private Limited at ₹2.76 Cr (FY 2025). Earlier, Madhav Hitesh Kumar was a Director at Sunapha Technologies Private Limited (2015–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Surgeway Biosciences Private Limited U46497KA2023PTC174184 | Director | 27 May 2023 | 2023 | ₹2.76 Cr (FY 2025) | Active |
 Dorphyll Healthcare Private Limited U24299KA2021PTC149000 | Director | 01 Jul 2021 | 2021 | ₹2.50 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sunapha Technologies Private Limited U52390KA2015PTC082991 | Director | 24 Sep 2015 | 2015 | ₹1,671 (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Madhav Hitesh Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shilpa | 09223071 | Surgeway Biosciences Private Limited , Dorphyll Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Madhav Hitesh Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madhav Hitesh Kumar
Madhav Hitesh Kumar currently holds 2 directorships: Surgeway Biosciences Private Limited (Director, since 27 May 2023, revenue ₹2.76 Cr (FY 2025)); Dorphyll Healthcare Private Limited (Director, since 01 Jul 2021, revenue ₹2.50 Cr (FY 2025)).
Madhav Hitesh Kumar was first appointed on 24 Sep 2015 as Director at Sunapha Technologies Private Limited. The most recent appointment on record is 27 May 2023 at Surgeway Biosciences Private Limited.
The 2 current companies of Madhav Hitesh Kumar that report revenue have a combined latest revenue of ₹5.26 Cr: Surgeway Biosciences Private Limited ₹2.76 Cr (FY 2025); Dorphyll Healthcare Private Limited ₹2.50 Cr (FY 2025).
Madhav Hitesh Kumar held 1 earlier board appointment: Sunapha Technologies Private Limited (Director, 24 Sep 2015 to 31 Mar 2024).
The current boards of Madhav Hitesh Kumar's companies include Shilpa (Surgeway Biosciences Private Limited).